chr14-22589093-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001344.4(DAD1):āc.65A>Gā(p.Gln22Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000249 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001344.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DAD1 | NM_001344.4 | c.65A>G | p.Gln22Arg | missense_variant | 1/3 | ENST00000250498.9 | NP_001335.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DAD1 | ENST00000250498.9 | c.65A>G | p.Gln22Arg | missense_variant | 1/3 | 1 | NM_001344.4 | ENSP00000250498 | P1 | |
DAD1 | ENST00000543337.1 | c.65A>G | p.Gln22Arg | missense_variant | 1/3 | 3 | ENSP00000440821 | |||
DAD1 | ENST00000538631.1 | c.65A>G | p.Gln22Arg | missense_variant | 1/2 | 2 | ENSP00000440242 | |||
DAD1 | ENST00000535847.1 | c.65A>G | p.Gln22Arg | missense_variant, NMD_transcript_variant | 1/3 | 2 | ENSP00000442074 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000414 AC: 104AN: 251408Hom.: 0 AF XY: 0.000397 AC XY: 54AN XY: 135894
GnomAD4 exome AF: 0.000243 AC: 355AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.000250 AC XY: 182AN XY: 727248
GnomAD4 genome AF: 0.000309 AC: 47AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.65A>G (p.Q22R) alteration is located in exon 1 (coding exon 1) of the DAD1 gene. This alteration results from a A to G substitution at nucleotide position 65, causing the glutamine (Q) at amino acid position 22 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at